Utilizing the data of the CheckMate 9ER trial, researchers believe that combination therapies in the treatment of patients with renal cell carcinoma are the future of the landscape.
Bradley McGregor, M.D.
Advertisement
Articles by Bradley McGregor, M.D.
Advertisement
Latest Updated Articles
Combination Therapies Open New Doors in Renal Cell Carcinoma StudiesPublished: February 26th 2020 | Updated:
Advertisement
Advertisement
Trending on CURE
1
What to Know About the FDA Approval of Blenrep for Multiple Myeloma
2
FDA Grants Exousia Pro Orphan Drug Designation in Glioma
3
Sharing Insights Into a Multiple Myeloma Journey
4
With Cancer, 'Your Outlook Will be Significant in Beating this Disease'
5
